Skip to main content
SpringerLink
Log in

Establishing Correlations Between the Pharmacodynamic Characteristics of Opioid Agonists and Their Behavioral Effects

  • Chapter
Opioids II

Part of the book series: Handbook of Experimental Pharmacology ((HEP,volume 104 / 2))

Abstract

In opioid pharmacology both the development of pharmacodynamic concepts and knowledge in behavioral preparations and the use of pharmacodynamic concepts and knowledge to explain results from behavioral preparations have a rich history (e.g., Martin 1967). At present, knowledge about the pharmacodynamics of opioid agonists continues to increase from work performed in a variety of systems which range from the behavioral to the molecular. One goal of much of the work in our laboratory has been to continue to expand the process of applying pharmacodynamic knowledge to the task of understanding the behavioral effects of opioid agonists across a wide range of conditions.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonists. Br J Pharmacol 14:48–58

    CAS  Google Scholar 

  • Bagley JR, Wynn RL, Rudo FG, Doorley BM, Spencer HK, Spaulding T (1989) New (heteroanilido) piperidines, structurally related to the pure opioid agonist fentanyl, with agonist and/or antagonist properties. J Med Chem 32:663–671

    Article  PubMed  CAS  Google Scholar 

  • Bertalmio AJ, Woods JH (1987) Differentiation between μ and к receptor-mediated effects in opioid drug discrimination: apparent pA2 analysis. J Pharmacol Exp Ther 243:591–597

    PubMed  CAS  Google Scholar 

  • Bertalmio AJ, Woods JH (1989) Reinforcing effect of alfentanil is mediated by μ opioid receptors: apparent pA2 analysis. J Pharmacol Exp Ther 251:455–460

    PubMed  CAS  Google Scholar 

  • Bertalmio AJ, Woods JH (1992) Discriminative stimulus effects of cyclorphan: selective antagonism with naltrexone. Psychopharmacology (Berl) 106:189–194

    Article  CAS  Google Scholar 

  • Collins RJ, Weeks JR, Cooper MM, Good PI, Russell RR (1984) Prediction of abuse liability of drugs using IV self-administration by rats. Psychopharmacology (Berl) 82:6–13

    Article  CAS  Google Scholar 

  • Colpaert FC, Niemegeers CJE, Janssen PAJ (1975) Investigations on drug produced and subjectively experienced discriminative stimuli. II. Loperamide, an antidiarrheal devoid of narcotic cue producing actions. Life Sci 16:717–728

    Article  PubMed  CAS  Google Scholar 

  • Cowan A, Tallarida RJ, Maslow J, Adler MW (1977) Quantitative assessment of the naloxone-ethylketazocine interaction using the rat tail compression test (Abstr). Pharmacologist 19:140

    Google Scholar 

  • Dykstra LA, Woods JH (1986) A tail withdrawal procedure for assessing analgesic activity in rhesus monkeys. J Pharmacol Methods 15:263–269

    Article  PubMed  CAS  Google Scholar 

  • Dykstra LA, Gmerek DE, Winger G, Woods JH (1987) к opioid agonists in rhesus monkeys. II. Analysis of the antagonistic actions of quadazocine and β- funaltrexamine. J Pharmacol Exp Ther 241:421–427

    Google Scholar 

  • Dykstra LA, Bertalmio AJ, Woods JH (1988) Discriminative and analgesic effects of µ and к opioids: in vivo pA2 analysis. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, p 107

    Google Scholar 

  • Errick JG, Heel RC (1983) Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs 26:191–211

    Article  PubMed  CAS  Google Scholar 

  • Fang FG, Fields HL, Lee NM (1986) Action at the μ receptor is sufficient to explain the supraspinal analgesic effect of opiates. J Pharmacol Exp Ther 238:1039–1044

    PubMed  CAS  Google Scholar 

  • France CP, Snyder AM, Woods JH (1989a) Analgesic effects of phencyclidine-like drugs in rhesus monkeys. J Pharmacol Exp Ther 251:197–201

    Google Scholar 

  • France CP, Woods JH, Iorio MA (1989b) Novel opioid agonists structurally related to haloperidol. Adv Biosci 75:89–92

    CAS  Google Scholar 

  • France CP, de Costa BR, Jacobson AE, Rice KC, Woods JH (1990a) Apparent affinity of opioid antagonists in morphine-treated rhesus monkeys discriminating between saline and naltrexone. J Pharmacol Exp Ther 252:600–604

    PubMed  CAS  Google Scholar 

  • France CP, Winger G, Medzihradsky F, Smith CB, Woods JH, Seggel M, Rice K (1990b) In vitro and in vivo characterization of a fentanil-related compound with opioid agonist and antagonist effects. In: van Ree JM, Mulder AH, Wiegant VM, van Wimersma Greidanus TB (eds) New leads in opioid research. Excerpta Medica, Amsterdam, p 71

    Google Scholar 

  • Fraser HF, Kay DC, Yeh SY, Gorodetzky CW, Dewey WL (1978) Possible effects of normetabolites on the subjective and reinforcing characteristics of opioids in animals and man. Drug Alcohol Depend 3:301–318

    Article  PubMed  CAS  Google Scholar 

  • Herling S, Woods JH (1981) Discriminative stimulus effects of narcotics: evidence for multiple receptor-mediated actions. Life Sci 28:1571–1584

    Article  PubMed  CAS  Google Scholar 

  • Herling S, Coale EH, Valentino RJ, Hein DW, Woods JH (1980) Narcotic discrimination in pigeons. J Pharmacol Exp Ther 214:139–146

    PubMed  CAS  Google Scholar 

  • Herling S, Hein DW, Nemeth MA, Valentino RJ, Woods JH (1982) Discriminative stimulus, antagonist, and rate-decreasing effects of cyclorphan: multiple modes of action. Life Sci 30:331–341

    Article  PubMed  CAS  Google Scholar 

  • Herling S, Solomon RE, Woods JH (1983) Discriminative stimulus effects of dextrorphan in pigeons. J Pharmacol Exp Ther 227:723–731

    PubMed  CAS  Google Scholar 

  • Koek W, Woods JH (1989) Partial generalization in pigeons trained to discriminate morphine from saline: applications of receptor theory. Drug Dev Res 16: 169–181

    Article  CAS  Google Scholar 

  • Kosterlitz HW, Waterfield AA, Berthoud V (1974) Assessment of the agonist and antagonist properties of narcotic analgesic drugs by their actions on the morphine receptor in the guinea pig ileum. Adv Biochem Psychopharmacol 8:319

    Google Scholar 

  • Martin WR (1967) Opioid antagonists. Pharmacol Rev 19:463–521

    PubMed  CAS  Google Scholar 

  • Picker MJ, Dykstra LA (1987) Comparison of the discriminative stimulus properties of U50,488 and morphine in pigeons. J Pharmacol Exp Ther 243:938–945

    PubMed  CAS  Google Scholar 

  • Picker MJ, Dykstra LA (1989) Discriminative stimulus effects of μ and к opioids in the pigeon: analysis of the effects of full and partial μ and к agonists. J Pharmacol Exp Ther 249:557–566

    PubMed  CAS  Google Scholar 

  • Schild HO (1947) pA2, a new scale for the measurement of drug antagonism. Br J Pharmacol 2:189–206

    CAS  Google Scholar 

  • Shannon HE, Holtzman SG (1979) Morphine training dose: a determinant of stimulus generalization to narcotic antagonists in the rat. Psychopharmcology (Berl) 61:239–244

    Article  CAS  Google Scholar 

  • Takemori AE (1974) Determination of pharmacological constants: use of narcotic antagonists to characterize analgesic receptors. Adv Biochem Psychopharmacol 8:335

    Google Scholar 

  • Walker EA (1989) Apparent -affinity and efficacy estimates for opioids in rhesus monkeys. Doctoral dissertation, University of Michigan. University Microfilms International, Ann Arbor Wallenstein

    Google Scholar 

  • SL, Rogers A, Kaiko RF, Heidrech G, Houde RW (1980) Relative analgesic potency of oral zomepirac and intramuscular morphine in cancer patients with postoperative pain. J Clin Pharmacol 20:250–258

    PubMed  CAS  Google Scholar 

  • Ward SJ, Pierson AK, Michne WF (1983) Multiple opioid receptor profile in vitro and activity in vivo of the potent opioid antagonist WIN 44,441–3. Life Sci 33 Suppl 1:303–306

    Google Scholar 

  • Winger D, Bertalmio AJ, Woods JH (1982) Discriminative and reinforcing properties of the normetabolites of propoxyphene and meperidine. In: Colpaert FC, Slagen JL (eds) Drug discrimination: applications in CNS pharmacology. Elsevier, Amsterdam, p 123

    Google Scholar 

  • Wood PL, Pilapil C, Thakur M, Richard JW (1984) WIN 44,441–3: a stereospecific and long-acting narcotic antagonist. Pharm Res 1:46–48

    Article  Google Scholar 

  • Woods JH, Young AM, Medzihradsky F, Smith CD, Aceto MD, Harris LS, Jacobson AE (1983) Zomepirac: preclinical narcotic abuse liability evaluation. Arzneimittelforschung 33:218–222

    PubMed  CAS  Google Scholar 

  • Woods JH, France CP, Bertalmio AJ, Gmerek DE, Winger G (1985) Behavioral assessment of insurmountable narcotic agonists and antagonists. In: Seiden LS, Balster RL (eds) Behavioral pharmacology: the current status. Liss, New York, p 72

    Google Scholar 

  • Woods JH, Bertalmio AJ, Young AM, Essman WD, Winger G (1988) Receptor mechanisms of opioid drug discrimination. In: Colpaert FC, Balster RL (eds) Transduction mechanisms of drug stimuli. Springer, Berlin Heidelberg New York, p 95

    Google Scholar 

  • Woods JH, Medzihradsky F, Smith CB, Winger GD, France CP (1991) Annual report: evaluation of new compounds for opioid activity. In: Harris LS (ed) Proceedings of the committee on problems of drug dependence. NIDA Res Monogr 119:559

    Google Scholar 

  • Young AM, Stephens KR (1984) Antagonism of the discriminative effects of ethylketazocine, cyclazocine and nalorphine in macaques. Psychopharmacology (Berl) 84:356–361

    Article  CAS  Google Scholar 

  • Young AM, Woods JH (1982) Limitations on the antagonist actions of opioid antagonists. Fed Proc 41:2333–2338

    PubMed  CAS  Google Scholar 

  • Young AM, Stephens KR, Hein DW, Woods JH (1984) Reinforcing and discriminative stimulus properties of mixed agonist-antagonist opioids. J Pharmacol Exp Ther 229:118–126

    PubMed  CAS  Google Scholar 

Download references

Authors
  1. A. J. Bertalmio
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. P. France
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J. H. Woods
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Abteilung Neuropharmakologie, Max-Planck-Institut für Psychiatrie, Am Klopferspitz 18, W-8033, Martinsried, Germany

    Albert Herz

  2. Mental Health Research Institute, School of Medicine, University of Michigan, 205 Zina Pitcher, 48109, Ann Arbor, MI, USA

    Huda Akil

  3. Medical Center, School of Medicine, New York University, 550 First Avenue, 10016, New York, NY, USA

    Eric J. Simon

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Bertalmio, A.J., France, C.P., Woods, J.H. (1993). Establishing Correlations Between the Pharmacodynamic Characteristics of Opioid Agonists and Their Behavioral Effects. In: Herz, A., Akil, H., Simon, E.J. (eds) Opioids II. Handbook of Experimental Pharmacology, vol 104 / 2. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-77540-6_18

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-77540-6_18

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-77542-0

  • Online ISBN: 978-3-642-77540-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation